Citadel Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Sell |
|
|||||
|
2025
Q1 | $4.85M | Buy |
|
|||||
|
2024
Q4 | $1.24M | Sell |
|
|||||
|
2024
Q3 | $28.2M | Buy |
|
|||||
|
2024
Q2 | $27.3M | Buy |
|
|||||
|
2024
Q1 | $19M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.33M | Buy |
|
|||||
|
2023
Q2 | $519K | Sell |
|
|||||
|
2023
Q1 | $2.99M | Buy |
|
|||||
|
2022
Q4 | $143K | Sell |
|
|||||
|
2022
Q3 | $1.54M | Sell |
|
|||||
|
2022
Q2 | $4.1M | Buy |
|
|||||
|
2022
Q1 | $3.4M | Sell |
|
|||||
|
2021
Q4 | $5.12M | Sell |
|
|||||
|
2021
Q3 | $6.35M | Sell |
|
|||||
|
2021
Q2 | $12M | Sell |
|
|||||
|
2021
Q1 | $13.1M | Buy |
|
|||||
|
2020
Q4 | $3.76M | Buy |
|
|||||
|
2020
Q3 | $450K | Sell |
|
|||||
|
2020
Q2 | $1M | Sell |
|
|||||
|
2020
Q1 | $1.66M | Buy |
|